Volume 6 Issue 6
Nov.  2015
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2015  >  6(6): 378-381
Yi Huimin, Wei Xuxia, Li Lijuan, et al. Sepsis after liver transplantation: a report of one case and interpretation of International Guidelines for Management of Severe Sepsis and Septic Shock[J]. ORGAN TRANSPLANTATION, 2015, 6(6): 378-381. doi: 10.3969/j.issn.1674-7445.2015.06.006
Citation: Yi Huimin, Wei Xuxia, Li Lijuan, et al. Sepsis after liver transplantation: a report of one case and interpretation of International Guidelines for Management of Severe Sepsis and Septic Shock[J]. ORGAN TRANSPLANTATION, 2015, 6(6): 378-381. doi: 10.3969/j.issn.1674-7445.2015.06.006
shu

Sepsis after liver transplantation: a report of one case and interpretation of International Guidelines for Management of Severe Sepsis and Septic Shock

doi: 10.3969/j.issn.1674-7445.2015.06.006

  • Surgical Intensive Care Unit, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China

More Information
  • Corresponding author: Guo Yu, Email: 13556032882@126.com
  • Received Date: 2015-09-12
    Available Online: 2021-01-19
  • Publish Date: 2015-11-15
    Abstract
  •   Objective  To summarize the treatment experience of sepsis after liver transplantation.  Methods  The clinical features and treatment methods of 1 patient developing sepsis after liver transplantation, who was admitted and treated in the Surgical Intensive Care Unit of the Third Affiliated Hospital of Sun Yat-sen University in September 2014, were retrospectively studied. The interpretation of International Guidelines for Management of Severe Sepsis and Septic Shock (SSC Guidelines) and relevant literature were reviewed.  Results  One male patient at the age of 50 years old developed high fever and decrease of blood pressure at 1 d after liver transplantation, and was diagnosed as septic shock. The symptoms were relieved after the appropriate treatment like goal-directed fluid resuscitation, anti-infection and blood purification, etc. And the patient was discharged in stable conditions.  Conclusions  It is easy to develop infection after liver transplantation and the fatality rate of sepsis caused by infection is high. Once the sepsis occurs, clinicians must perform early goal-directed therapy and bundle therapy according to the SSC Guidelines positively, and select the appropriate drugs according to the pathogen culture results in order to reduce the fatality rate.

     

    • FullText(HTML)
  • loading
    • References(22)
  • [1]
    Drewry AM, Hotchkiss RS. Sepsis: revising definitions of sepsis[J]. Nat Rev Nephrol, 2015, 11(6):326-328. doi: 10.1038/nrneph.2015.66
    [2]
    Brown T, Ghelani-Allen A, Yeung D, et al. Comparative effectiveness of physician diagnosis and guideline definitions in identifying sepsis patients in the emergency department[J]. J Crit Care, 2015, 30(1):71-77. doi: 10.1016/j.jcrc.2014.08.009
    [3]
    Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?[J]. Virulence, 2014, 5(1):20-26. doi: 10.4161/viru.27135
    [4]
    Gu WJ, Wang F, Bakker J, et al. The effect of goal-directed therapy on mortality in patients with sepsis-earlier is better: a meta-analysis of randomized controlled trials[J]. Crit Care, 2014, 18(5):570. doi: 10.1186/s13054-014-0570-5
    [5]
    Wan YD, Sun TW, Kan QC, et al. Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies[J]. Crit Care, 2014, 18(2):R71. doi: 10.1186/cc13828
    [6]
    Page DB, Donnelly JP, Wang HE. Community-, healthcare-, and hospital-acquired severe sepsis hospitalizations in the University Health System Consortium[J]. Crit Care Med, 2015, 43(9):1945-1951. doi: 10.1097/CCM.0000000000001164
    [7]
    Goodwin AJ, Simpson KN, Ford DW. Volume-mortality relationships during hospitalization with severe sepsis exist only at low case volumes[J]. Ann Am Thorac Soc, 2015, 12(8):1177-1184. http://cn.bing.com/academic/profile?id=1645671388&encoded=0&v=paper_preview&mkt=zh-cn
    [8]
    胡海清, 周庭银, 唐德羽, 等.肝移植术后革兰阴性杆菌感染的种类及耐药性分析[J].实用医学杂志, 2008, 24(16) :2880-2882. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ200816084.htm

    Hu HQ, Zhou TY, Tang DY, et al. The analysis on kinds and drug resistance of gram negative bacillus infection after liver transplantation[J]. J Pract Med, 2008, 24(16): 2880-2882. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ200816084.htm
    [9]
    Fishbain J, Peleg AY. Treatment of acinetobacter infections[J]. Clin Infect Dis, 2010, 51(1):79-84. doi: 10.1086/652975
    [10]
    Munoz-Price LS, Weinstein RA. Acinetobacter infection[J]. N Engl J Med, 2008, 358(12):1271-1281. doi: 10.1056/NEJMra070741
    [11]
    Khwannimit B, Bhurayanontachai R. The epidemiology of, and risk factors for, mortality from severe sepsis and septic shock in a tertiary-care university hospital setting[J]. Epidemiol Infect, 2009, 137(9):1333-1341. doi: 10.1017/S0950268809002027
    [12]
    Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis[J]. Crit Care Med, 2010, 38(2):367-374. doi: 10.1097/CCM.0b013e3181cb0cdc
    [13]
    Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial[J]. JAMA, 2010, 303(8):739-746. doi: 10.1001/jama.2010.158
    [14]
    Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af
    [15]
    浙江省早期规范化液体复苏治疗协作组.危重病严重脓毒症/脓毒性休克患者早期规范化液体复苏治疗——多中心、前瞻性、随机、对照研究[J].中国危重病急救医学, 2010, 22(6):331-334. http://www.cqvip.com/QK/97432X/201006/34338168.html

    Early Goal-Directed Therapy Collaborative Group of Zhejiang Province. The effect of early goal-directed therapy on treatment of critical patients with severe sepsis/septic shock: a multi-center, prospective, randomized, controlled study[J]. Chin Crit Care Med, 2010, 22(6):331-334. http://www.cqvip.com/QK/97432X/201006/34338168.html
    [16]
    Sopirala MM, Mangino JE, Gebreyes WA, et al. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2010, 54(11):4678-4683. doi: 10.1128/AAC.00497-10
    [17]
    Entenza JM, Moreillon P. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies[J]. Int J Antimicrob Agents, 2009, 34(1):8.e1-8.e9. http://cn.bing.com/academic/profile?id=1999156712&encoded=0&v=paper_preview&mkt=zh-cn
    [18]
    刘朝晖, 苏磊, 廖银光, 等.脓毒症机械通气患者营养平衡对临床预后的影响[J].实用医学杂志, 2014, 30(14):2237-2239. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201414019.htm

    Liu CH, Su L, Liao YG, et al. Impact of energy balance on clinical outcome and complications in septic patients with mechanical ventilation[J]. J Pract Med, 2014, 30(14):2237-2239. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201414019.htm
    [19]
    Garnacho-Montero J, Amaya-Villar R. Multiresistant acinetobacter baumannii infections: epidemiology and management[J]. Curr Opin Infect Dis, 2010, 23(4):332-339. doi: 10.1097/QCO.0b013e32833ae38b
    [20]
    Phee LM, Betts JW, Bharathan B, et al. Colistin and fusidic acid, a novel potent synergistic combination for treatment of multidrug-resistant acinetobacter baumannii infections[J]. Antimicrob Agents Chemother, 2015, 59(8):4544-4550. doi: 10.1128/AAC.00753-15
    [21]
    Adibhesami H, Douraghi M, Rahbar M, et al. Minocycline activity against clinical isolates of multidrug-resistant acinetobacter baumannii[J]. Clin Microbiol Infect, 2015, 21(11):e79-e80.DOI: 10.1016/j.cmi.2015.07.007 [Epub ahead of print].
    [22]
    García-Salguero C, Rodríguez-Avial I, Picazo JJ, et al. Can plazomicin alone or in combination be a therapeutical option against carbapenem-resistant acinetobacter baumannii?[J]. Antimicrob Agents Chemother, 2015, 59(10):5959-5966. doi: 10.1128/AAC.00873-15
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (165) PDF downloads(27) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return